SESSION CODE:
[PL] Plenary Lecture, [SS] Scientific Symposium, [JS] Joint Symposium, [ES] Education Session,
[MDCD] Multi-Disciplinary Case Discussion, [OP] Oral Presentation, [LS] Luncheon Symposium, [SL] Satellite Symposium
| Sep.3 (WED) | Date | Sep.4 (THU) | ||||
|---|---|---|---|---|---|---|
| Room D | Time | Room A | Room B | Room C | Room D | Room E |
| 08:40-10:10 | JS 1 ASCO/KSMO |
JS 2 KCSG/KSMO |
ES 2 | SS 1 | SL 1 (8:40-9:20) |
|
| SL 2 (9:30-10:10) |
||||||
| 10:10-10:20 | Break (10 min.) | |||||
| 10:20-10:40 | Opening Ceremony (10:20-10:40) |
|||||
| 10:40-11:20 | PL 1 | |||||
| 11:20-11:30 | Break (10 min.) | |||||
| 11:30-12:10 | LS 1 | LS 2 | LS 3 | LS 4 | LS 5 | |
| 12:10-12:20 | Break (10 min.) | |||||
| 12:20-13:50 | SS 2 | ES 3 | SS 3 | JS 3 KOSRO/KSMO |
SL 3 (12:20-13:00) |
|
| SL 4 (13:10-13:50) |
||||||
| 13:50-14:00 | Break (10 min.) | |||||
| KSMO Initiatives for Cancer Care Inequity (14:00-16:00) |
14:00-15:30 | JS 4 ESMO/KSMO |
JS 5 KSSO/KSMO |
ES 4 | SS 4 | SL 5 (14:00-14:40) |
| SL 6 (14:50-15:30) |
||||||
| 15:30-15:40 | Break (10 min.) | |||||
| 15:40-16:20 | PL 2 | |||||
| Break (10 min.) | ||||||
| ES 1 (16:10-17:30) |
||||||
| 16:20-17:50 | SS 5 | OP 1 16:20-17:20 |
SS 6 | JS 6 KSR/KSMO |
SL 7 (16:20-17:00) |
|
| Break (10 min.) | ||||||
| Welcome Reception (17:40~) |
SL 8 (17:10-17:50) |
|||||
| Date | Sep.5 (FRI) | ||||
|---|---|---|---|---|---|
| Time | Room A | Room B | Room C | Room D | Room E |
| 08:40-10:10 | JS 7 JSMO/KSMO |
ES 5 | SS 7 | JS 8 KSP/KSMO |
SL 9 (8:40-9:20) |
| SL 10 (9:30-10:10) |
|||||
| 10:10-10:30 | Break (20 min.) | ||||
| 10:30-11:10 | PL 3 | ||||
| 11:10-11:30 | Break (20 min.) | ||||
| 11:30-12:10 | LS 6 | LS 7 | LS 8 | LS 9 | LS 10 |
| 12:10-12:20 | Break (10 min.) | ||||
| 12:20-13:50 | JS 9 ASCO/KSMO |
OP 2 12:20-13:20 |
MDCD | SS 8 | SL 11 (12:20-13:00) |
| SL 12 (13:10-13:50) |
|||||
| 13:50-14:00 | Break (10 min.) | ||||
| 14:00-14:40 | PL 4 | |
||||
| 14:40-14:50 | Break (10 min.) | ||||
| 14:50-16:20 | JS 10 ESMO/KSMO |
SS 9 | SS 10 | SL 13 (14:50-15:30) |
|
| SL 14 (15:40-16:20) |
|||||
| 16:20-16:40 | Closing Ceremony | ||||
| Date | Sep.3 (WED) |
|---|---|
| Time | Room D |
| 14:00-16:00 | KSMO Initiatives for Cancer Care Inequity |
| 16:00-16:10 | Break (10 min.) |
| 16:10-17:30 | ES 1 Symptom management in advanced cancer: Innovations and best practices |
| 17:30-17:40 | Break (10 min.) |
| 17:40~ | Welcome Reception |
| Date | Sep.4 (THU) | ||||
|---|---|---|---|---|---|
| Time | Room A | Room B | Room C | Room D | Room E |
| 08:40-10:10 | JS 1 ASCO/KSMO |
JS 2 KCSG/KSMO Transforming Oncology Research: AI-Powered Clinical Trials |
ES 2 Tumor heterogeneity and single-cell analysis KOR |
SS 1 Optimizing the transition to palliative care: Prognostic estimation and communication in oncology |
SL 1 (8:40-9:20) |
| SL 2 (9:30-10:10) |
|||||
| 10:10-10:20 | Break (10 min.) | ||||
| 10:20-10:40 | Opening Ceremony (10:20-10:40) |
||||
| 10:40-11:20 | PL 1 Breaking new ground: Innovative cancer vaccine therapies |
||||
| 11:20-11:30 | Break (10 min.) | ||||
| 11:30-12:10 | LS 1 | LS 2 | LS 3 | LS 4 | LS 5 |
| 12:10-12:20 | Break (10 min.) | ||||
| 12:20-13:50 | SS 2 Revolutionizing GI cancer care with next-generation modalities |
ES 3 Cancer survivorship: Shifting paradigms in care KOR |
SS 3 How shall we treat RARE cancer in the era of precision medicine : Progress and challenges ahead |
JS 3 KOSRO/KSMO Optimization of neoadjuvant/adjuvant treatment |
SL 3 (12:20-13:00) |
| SL 4 (13:10-13:50) |
|||||
| 13:50-14:00 | Break (10 min.) | ||||
| 14:00-15:30 | JS 4 ESMO/KSMO ESMO guideline and the implementation in Asian Pacific Region |
JS 5 KSSO/KSMO Omit surgery in GI cancer treatment |
ES 4 Toxicity management in Antibody-Drug Conjugates (ADCs) KOR |
SS 4 Current trends and future perspectives in GU oncology |
SL 5 (14:00-14:40) |
| SL 6 (14:50-15:30) |
|||||
| 15:30-15:40 | Break (10 min.) | ||||
| 15:40-16:20 | PL 2 Cancer cachexia: Transition from science to practice |
||||
| 16:20-17:50 | SS 5 Current insights and future directions of MBC treatment |
OP 1 16:20-17:20 |
SS 6 Clinical promise of ctDNA-based MRD testing in solid tumors |
JS 6 Radiomics revolution: AI and imaging in cancer care |
SL 7 (16:20-17:00) |
| SL 8 (17:10-17:50) |
|||||
| Date | Sep.5 (FRI) | ||||
|---|---|---|---|---|---|
| Time | Room A | Room B | Room C | Room D | Room E |
| 08:40-10:10 | JS 7 JSMO/KSMO The new standard therapy in solid tumors : The combination of immunotherapies |
ES 5 Advance of technology - Artificial Intelligence in Oncology KOR |
SS 7 Novel opportunities to target cancer: Emerging strategies in molecular oncology |
JS 8 KSP/KSMO Biomarker for ADC |
SL 9 (8:40-9:20) |
| SL 10 (9:30-10:10) |
|||||
| 10:10-10:30 | Break (20 min.) | ||||
| 10:30-11:10 | PL 3 Advances in chemotherapy for gastric cancer- Future perspectives |
||||
| 11:10-11:30 | Break (20 min.) | ||||
| 11:30-12:10 | LS 6 | LS 7 | LS 8 | LS 9 | LS 10 |
| 12:10-12:20 | Break (10 min.) | ||||
| 12:20-13:50 | JS 9 ASCO/KSMO |
OP 2 12:20-13:20 |
MDCD Personalized treatment strategies for oligometastatic patients in the new era of cancer therapeutics KOR |
SS 8 Combinatory strategy to enhance immune checkpoint response |
SL 11 (12:20-13:00) |
| SL 12 (13:10-13:50) |
|||||
| 13:50-14:00 | Break (10 min.) | ||||
| 14:00-14:40 | PL 4 Biomarkers to predict efficacy and toxicity of antibody drug conjugates in breast cancer. |
||||
| 14:40-14:50 | Break (10 min.) | ||||
| 14:50-16:20 | JS 10 ESMO/KSMO How to streamline initiatives for optimising oncology practice |
SS 9 Real-world challenges in GI oncology: Navigating complex treatment decisions |
SS 10 Revealing immune response and resistance through spatial profiling of NSCLC microenvironment |
SL 13 (14:50-15:30) |
|
| SL 14 (15:40-16:20) |
|||||
| 16:20-16:40 | Closing Ceremony | ||||